Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

29 Apr 2021 07:00

RNS Number : 9520W
Chesnara PLC
29 April 2021
 

CHESNARA plc

("Chesnara" or "the Company")

 

29 April 2021

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ('PDMRs')

 

Chesnara plc (the 'Company') today announces that, as at 28 April 2021, John Deane and David Rimmington (each a PDMR) were granted awards in the ordinary shares of the Company under the Chesnara plc Long Term and Short Term Schemes. These awards were made in accordance with the Directors' Remuneration Policy.

 

The notifications for each PDMR below, which are being made in accordance with the requirements of the EU Market Abuse Regulations, provide further detail of the awards granted to each PDMR.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

John Deane

2

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2014 Short-term Incentive Scheme. The option is not subject to a performance target.

 

The option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target over a period of three financial years.

 

Subject to the achievement of the performance target, the option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

31,065 Ordinary shares of 5p each

Nil

GRANT 2

166,453 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

- 197,518 ORDINARY SHARES OF 5P EACH

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2021-04-28

f)

Place of the transaction

XOFF

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

David Rimmington

2

Reason for the notification

a)

Position/status:

Chief Finance Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

(GB00B00FPT80)

b)

Nature of the transaction

GRANT 1

Granted under the Chesnara 2014 Short-term Incentive Scheme. The option is not subject to a performance target.

 

The option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date.

 

GRANT 2

Granted under the Chesnara 2014 Long-term Incentive Scheme. The option is subject to a performance target over a period of three financial years.

 

Subject to the achievement of the performance target, the option will become exercisable on 28 April 2024 and remain exercisable up to and including 27 April 2031 if not exercised before that date.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

18,803 Ordinary shares of 5p each

Nil

GRANT 2

94,502 Ordinary shares of 5p each

d)

Aggregated information

- Aggregated volume

- Price

 

113,305 ORDINARY SHARES OF 5P EACH

Nil

e)

Date of the transaction (YYYY - MM - DD)

2021-04-28

f)

Place of the transaction

XOFF

 

Name of authorised official of issuer responsible for making notification: - Al Lonie

 

Date of notification: - 29 April 2021

 

 

 

For further information, please contact:

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 16 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUCUCUPGGCR
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.